Chargement en cours...
UGT genotyping in belinostat dosing
Certain genetic polymorphisms of UDP glucuronosyltransferase 1 family, polypeptide A1 (UGT1A1) can reduce gene expression (*28, *60, *93) or activity (*6), thereby altering the pharmacokinetics, pharmacodynamics, and the risk of toxicities of UGT1A1 substrates, of which irinotecan is a widely-descri...
Enregistré dans:
| Publié dans: | Pharmacol Res |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4775324/ https://ncbi.nlm.nih.gov/pubmed/26773202 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.phrs.2016.01.002 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|